MktsMarkets

Cytosorbents Corporation
NASDAQ: CTSOKey statistics
CTSO News
Stories mentioning CTSO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | 2,734 | 2,430 | 2,819 | 2,803 | 2,520 | 2,896 | 3,357 | 2,339 |
| Gross Profit | 6,130 | 6,804 | 6,666 | 6,814 | 6,207 | 6,254 | 5,256 | 6,503 |
| Operating Expenses | ||||||||
| Research & Development | 1,025 | 1,663 | 1,851 | 1,520 | ||||
| Sales General & Admin | 8,149 | 9,436 | 8,610 | 9,167 | 8,432 | 7,635 | 8,260 | 8,554 |
| Total Operating Expenses | 9,174 | 11,188 | 9,528 | 10,429 | 10,095 | 9,650 | 10,086 | 10,073 |
| Operating Income (Loss) | (3,044) | (4,384) | (2,862) | (3,615) | (3,888) | (3,396) | (4,830) | (3,570) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (3,571) | (1,478) | (9,410) | (2,768) | (4,143) | |||
| Tax Provision | 0.00 | (401.00) | 0.00 | 0.00 | ||||
| Net Income (Loss) | (5,129) | (5,496) | (3,170) | 1,947 | (1,479) | (7,568) | (2,768) | (4,294) |
| Earnings Per Share (Basic) | (0.08) | (0.09) | (0.05) | 0.03 | (0.02) | (0.14) | (0.05) | (0.08) |
| Earnings Per Share (Diluted) | (0.08) | (0.09) | (0.05) | 0.03 | (0.02) | (0.14) | (0.05) | (0.08) |
| Weighted Average Shares Outstanding (Basic) | 62,739 | 62,232 | 62,754 | 62,609 | 60,732 | 54,435 | 54,453 | 54,306 |
| Weighted Average Shares Outstanding (Diluted) | 62,739 | 62,232 | 62,754 | 67,166 | 60,732 | 54,435 | 54,453 | 54,306 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CTSO
Cytosorbents Corporation (NASDAQ: CTSO) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTSO. It last traded at $5.27 (Oct 23, 2026, 4:00 PM ET), down 12.3% on the day. That gives Cytosorbents a market capitalisation of $16.6M.
Over the past 52 weeks CTSO has traded between $2.84 and $17.28.
For the quarter ended Mar 31, 2026 it reported a net loss of $5.1M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$5.1M |
| Dec 31, 2025 | — | -$5.5M |
| Sep 30, 2025 | — | -$3.2M |
| Jun 30, 2025 | — | $1.9M |
From Cytosorbents’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…